Kyverna Therapeutics Ownership | Who Owns Kyverna Therapeutics?
Kyverna Therapeutics Ownership Summary
Kyverna Therapeutics is owned by 53.67% institutional investors, 12.03% insiders, and 34.30% retail investors. Vida ventures advisors is the largest institutional shareholder, holding 10.47% of KYTX shares.
KYTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Kyverna Therapeutics | 53.67% | 12.03% | 34.30% |
| Sector | Healthcare Stocks | 487.91% | 11.08% | -398.99% |
| Industry | Biotech Stocks | 306.69% | 11.10% | -217.79% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vida ventures advisors | 4.52M | 10.47% | $27.14M |
| Bain capital life sciences investors | 3.37M | 7.79% | $10.34M |
| Insight group | 989.05K | 2.29% | $3.04M |
| Mbb public markets i | 614.48K | 1.42% | $1.89M |
| Blackrock funding, inc. /de | 533.47K | 1.23% | $1.64M |
| Kera capital partners | 421.92K | 0.98% | $2.53M |
| Superstring capital management lp | 142.54K | 0.33% | $437.60K |
| Marshall wace, llp | 62.06K | 0.14% | $190.51K |
| Point72 asset management | 55.52K | 0.13% | $170.45K |
| Prelude capital management | 36.25K | 0.08% | $111.28K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Vida ventures advisors | 4.52M | 92.41% | $27.14M |
| Bain capital life sciences investors | 3.37M | 1.29% | $10.34M |
| Caxton | 22.98K | 0.72% | $70.55K |
| Superstring capital management lp | 142.54K | 0.52% | $437.60K |
| Kera capital partners | 421.92K | 0.38% | $2.53M |
| Mbb public markets i | 614.48K | 0.18% | $1.89M |
| Insight group | 989.05K | 0.13% | $3.04M |
| Phoenix wealth advisors | 10.50K | 0.02% | $63.00K |
| Prelude capital management | 36.25K | 0.01% | $111.28K |
| Point72 asia (singapore) pte. | 12.04K | 0.01% | $36.96K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 55.52K | 0.00% | 55.52K |
| Marshall wace, llp | 62.06K | 0.00% | 37.50K |
| Xtx topco | 34.94K | 0.00% | 34.94K |
| Hrt financial lp | 20.17K | 0.00% | 20.17K |
| Qube research | 14.05K | - | 14.05K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Novo | - | - | -1.85M |
| Blackrock funding, inc. /de | 533.47K | - | -1.14M |
| Integral health asset management | - | - | -350.00K |
| Ameriprise financial | - | - | -190.38K |
| Rock springs capital management lp | - | - | -178.96K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Point72 asset management | 55.52K | 0.00% | 55.52K | $170.45K |
| Hrt financial lp | 20.17K | 0.00% | 20.17K | $61.00K |
| Qube research | 14.05K | - | 14.05K | $43.14K |
| Point72 asia (singapore) pte. | 12.04K | 0.01% | 12.04K | $36.96K |
| Capital advisors inc/ok | 10.00K | 0.00% | 10.00K | $60.00K |
Sold Out
| Holder | Change |
|---|---|
| Rothschild investment | -50.00 |
| Jones financial companies lllp | -81.00 |
| Sterling capital management | -186.00 |
| True wealth design | -220.00 |
| Physician wealth advisors | -420.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 79 | -10.23% | 23,198,522 | -10.03% | 53 | 1.51% | 44 | 4.76% | 24 | -4.00% |
| Mar 31, 2025 | 88 | -1.12% | 25,809,724 | -9.40% | 59 | 1.37% | 41 | -26.79% | 25 | 92.31% |
| Dec 31, 2024 | 90 | -4.26% | 28,867,980 | 2.72% | 66 | 1.58% | 57 | 11.76% | 13 | -38.10% |
| Sep 30, 2024 | 94 | 4.44% | 28,104,372 | -12.02% | 65 | 1.19% | 51 | -19.05% | 21 | 90.91% |
| Jun 30, 2024 | 90 | -2.17% | 31,942,911 | 4.22% | 74 | 0.44% | 63 | -29.21% | 11 | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 12, 2024 | GILEAD SCIENCES, INC. | - | Buy | $20.02M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
| 2024 Q1 | 1 | - |
KYTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools